表紙
市場調査レポート

CountryFocus:フィリピンの医療・規制・医療費償還制度の状況

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines

発行 GlobalData 商品コード 301408
出版日 ページ情報 英文 199 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
CountryFocus:フィリピンの医療・規制・医療費償還制度の状況 CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines
出版日: 2016年08月16日 ページ情報: 英文 199 Pages
概要

フィリピンの総人口は2013年には9920万人に達し、世界第12位の人口大国となっています。出生率の高さと平均余命の改善が人口増大の主な要因となっています。一方で、高齢者人口の増加が政策立案者にとっての懸念事項となっています。フィリピンの医薬品市場は、2013年には43億米ドルに達し、さらに2020年には約80億米ドルにまで拡大する(その間の年平均成長率(CAGR)は9.4%)、と予測されています。

当レポートでは、フィリピンの医療関連市場の動向や、医療費償還制度およびその他の関連規制・制度について分析し、医薬品産業・医療装置産業の全体的構造・動向、医療費償還制度やその周辺の保険市場の動向、医療規制当局の構造や各種規制の概要、フィリピン経済・社会に関するマクロ的指標(医療インフラなど)、今後の市場機会と課題といった情報を取りまとめて、概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

第3章 医薬品・医療機器市場の概要

  • 医薬品市場
    • 市場概況
    • 医薬品の輸出入
    • 供給経路
    • 市場の分類
    • 主な疾患分野の概要
    • 主要企業
  • 医療機器市場
    • 市場概況
  • 市場の促進・阻害要因
    • 促進要因
    • 阻害要因

第4章 市場へのアクセス

  • 医療費償還・保険料支払者の状況
    • 医療制度の概要
    • 医療費償還の過程
    • 保険業者の概要
    • 医療費支出に対する患者負担の比率
    • 医療サービスの価格動向
    • 薬価政策
  • 規制環境
    • 規制機関の概要
    • 医薬品の販売認証過程
    • 医療機器の新製品の認証過程
    • 医薬品・医療機器の製造認可過程
    • 医薬品の輸出入
    • 知的所有権
    • 治験関連の規制
    • 医薬品の広告に関する規制
    • 薬局関連の規制
    • ラベリング・包装に関する規制

第5章 国の分析

  • 政治環境
  • 経済環境
  • 経済指標
  • 人口統計
  • 医療インフラ
    • 医療施設
    • 医療関連パラメーター
    • 環境問題
    • 医療従事者
  • 医療費支出
    • 概要
    • 医療費支出の主な要素
    • 公共/民間部門のシェア
    • 医薬品の研究開発(R&D)活動への支出額
  • 業界団体
  • 展示会

第6章 市場機会と課題

  • 市場機会
  • 課題

第7章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC0060CHR

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Philippines. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Philippines. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

In 2015, Philippines population was approximately at 100.9 million. The government of Philippines has been making continuous efforts to strengthen the economy to ensure long-term growth, and the pharmaceutical market is seen as a key industry for the country's future growth. To support this industry, the government has improved regulatory guidelines and initiatives to develop the domestic pharmaceutical market. The Philippines pharmaceutical market is the third-largest pharmaceutical market in the Association of Southeast Asian Nations (ASEAN), after Indonesia and Thailand. The Pharmaceutical market was estimated to be worth $3.4 billion in 2015 and expected to reach $4.1 billion by 2020. The market grew nominally at a Compound Annual Growth Rate (CAGR) of 3.7% over the 2008-2020 period. The medical device market was valued at $400m in 2008 and is expected to reach approximately $600m by 2020, at a projected CAGR of 8.1%.

These positive trends can primarily be attributed to -

  • An increasing elderly population in Philippines, leading to increases in disease incidence and prevalence as well as higher need for long-term care and medical devices
  • Increasing awareness in the medical community and the general population regarding early disease detection and diagnosis, leading to higher rates of adoption of treatments and healthcare

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Philippines, and includes -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (United Laboratories, Pfizer, GlaxoSmithKline, Novartis, Merck Co.)
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the Philippines healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -

  • Develop business strategies by understanding the trends shaping and driving Philippines healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in Philippines healthcare market

Table of Contents

1 Table of Contents

1 Table of Contents 6

  • 1.1 List of Tables 9
  • 1.2 List of Figures 12

2 Introduction 16

  • 2.1 GlobalData Report Guidance 16

3 Overview of Pharmaceutical and Medical Device Market 17

  • 3.1 Pharmaceutical Market 17
    • 3.1.1 Market Overview 17
    • 3.1.2 Pharmaceutical Exports and Imports 21
    • 3.1.3 Supply Channels 22
    • 3.1.4 Market Segments 23
    • 3.1.5 Overview of Major Disease Areas 25
    • 3.1.6 Major Players 28
  • 3.2 Medical Device Market 67
    • 3.2.1 Market Overview 67
  • 3.3 Market Drivers and Barriers 67
    • 3.3.1 Drivers 67
    • 3.3.2 Barriers 68

4 Market Access 70

  • 4.1 Reimbursement and Payer Landscape 70
    • 4.1.1 Overview of Healthcare System 70
    • 4.1.2 Reimbursement Process 71
    • 4.1.3 Overview of Insurance Providers 75
    • 4.1.4 Patient Share in Healthcare Spending 80
    • 4.1.5 Price Trends in the Healthcare Sector 82
    • 4.1.6 Pricing Policies 83
  • 4.2 Regulatory Landscape 84
    • 4.2.1 Overview of Regulatory Agencies 84
    • 4.2.2 Market Authorization Procedure for Pharmaceutical Products 85
    • 4.2.3 New Medical Device Approval Process 91
    • 4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 91
    • 4.2.5 Exports and Imports 92
    • 4.2.6 Intellectual Property Rights 95
    • 4.2.7 Clinical Trial Regulations 99
    • 4.2.8 Pharmaceutical Advertising Regulations 102
    • 4.2.9 Pharmacy Regulations 103
    • 4.2.10 Labeling and Packaging Regulations 104

5 Country Analysis 106

  • 5.1 Political Environment 106
    • 5.1.1 Political Structure 106
    • 5.1.2 Analysis of Current Political Environment 107
    • 5.1.3 Healthcare Policy Initiatives 108
  • 5.2 Economic Landscape 113
  • 5.3 Economic Indicators 118
    • 5.3.1 Gross Domestic Product 118
    • 5.3.2 Gross National Income 122
    • 5.3.3 Inflation 123
    • 5.3.4 Currency Exchange Rate 125
    • 5.3.5 Foreign Direct Investment 126
    • 5.3.6 Foreign Exchange Reserves 127
    • 5.3.7 Trade Balance 128
    • 5.3.8 Fiscal Deficit 130
    • 5.3.9 General Government Gross Debt 131
    • 5.3.10 External Debt 132
    • 5.3.11 Major Industries 133
  • 5.4 Demographics 136
    • 5.4.1 Population 136
    • 5.4.2 Education and Literacy 153
    • 5.4.3 Employment 155
    • 5.4.4 Disease Burden 156
  • 5.5 Healthcare Infrastructure 159
    • 5.5.1 Healthcare Facilities 159
    • 5.5.2 Healthcare Parameters 164
    • 5.5.3 Environmental Health 165
    • 5.5.4 Healthcare Personnel 167
  • 5.6 Healthcare Expenditure 170
    • 5.6.1 Overview 170
    • 5.6.2 Major Components of Healthcare Spending 171
    • 5.6.3 Share of Public and Private Sector 172
    • 5.6.4 Spending in Pharmaceutical R&D 173
  • 5.7 Trade Associations 173
    • 5.7.1 Pharmaceutical and Healthcare Association of the Philippines 173
    • 5.7.2 The Philippine Pharmaceutical Manufacturers Association 173
    • 5.7.3 The Philippine Pharmacist Association 173
    • 5.7.4 The Philippine Medical Association 174
  • 5.8 Trade Fairs 174

6 Opportunities and Challenges 175

  • 6.1 Opportunities 175
  • 6.2 Challenges 175

7 Appendix 178

  • 7.1 Abbreviations 178
  • 7.2 Bibliography 181
  • 7.3 Research Methodology 196
    • 7.3.1 Coverage 196
    • 7.3.2 Secondary Research 196
    • 7.3.3 Forecasts 197
    • 7.3.4 Expert Panel 197
  • 7.4 Disclaimer 198

List of Tables

1.1 List of Tables

  • Table 1: Pharmaceutical Market, Philippines, Revenue ($bn), 2008-2015 20
  • Table 2: Pharmaceutical Market, Philippines, Revenue Forecast ($bn), 2016-2020 20
  • Table 3: Pharmaceutical Market, Philippines, Exports and Imports ($m), 2008-2014 21
  • Table 4: Pharmaceutical Market, Philippines, Price Distribution of Pharmaceuticals for Multinational Companies (%), 2008 23
  • Table 5: Pfizer, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2015 34
  • Table 6: Pharmaceutical Market, Pfizer, Late-Stage Pipeline, 2016 35
  • Table 7: GlaxoSmithKline, Global, Major Products Revenue ($m) and Annual Growth (%), 2015 42
  • Table 8: Pharmaceutical Market, GlaxoSmithKline, Late-Stage Pipeline, 2016 43
  • Table 9: Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2015 50
  • Table 10: Pharmaceutical Market, Novartis, Planned Filings, 2014-2018 51
  • Table 11: Merck & Co., Global, Major Products, Revenue ($bn) and Annual Growth (%), 2015 59
  • Table 12: Pharmaceutical Market, Global, Late-Stage Pipeline, Merck & Co., 2016 60
  • Table 13: Membership in PhilHealth, Philippines, Sector Share (%), 2016 78
  • Table 14: Benefit Payments from PhilHealth, Philippines, Sector Share (%), 2016 79
  • Table 15: Healthcare Spending, Philippines, Out-of-Pocket Expenditure (%), 2008-2015 81
  • Table 16: Price of Healthcare Products, Philippines Change in Average Price of Health Sector (%), 2008-2014 82
  • Table 17: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2008-2015 118
  • Table 18: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2016-2020 119
  • Table 19: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2008-2015 120
  • Table 20: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2016-2020 121
  • Table 21: Economic Indicators, Philippines, Gross National Income per Capita ($), 2008-2014 122
  • Table 22: Economic Indicators, Philippines, Average Consumer Price Index, 2008-2013 123
  • Table 23: Economic Indicators, Philippines, Average Consumer Price Annual Change (%), 2008-2013 124
  • Table 24: Economic Indicators, Philippines, Currency Exchange Rate (PHP/$), 2008-2015 125
  • Table 25: Economic Indicators, Philippines, Foreign Direct Investment ($bn), 2008-2014 126
  • Table 26: Economic Indicators, Philippines, Foreign Exchange Reserves ($bn), 2008-2014 127
  • Table 27: Economic Indicators, Philippines, Imports of Goods and Services ($bn), 2008-2015 128
  • Table 28: Economic Indicators, Philippines, Exports of Goods and Services ($bn), 2008-2015 129
  • Table 29: Economic Indicators, Philippines, Fiscal Deficit (% of GDP), 2008-2014 130
  • Table 30: Economic Indicators, Philippines, General Government Gross Debt (% of GDP), 2008-2015 131
  • Table 31: Economic Indicators, Philippines, External Debt ($bn), 2008-2015 132
  • Table 32: Economic Indicators, Philippines, Major Industries, Industrial Sector, Gross Value Added ($bn), 2012-2013 134
  • Table 33: Economic Indicators, Philippines, Major Industries, Service Sector, Gross Value Added ($bn), 2013-2014 135
  • Table 34: Demographics, Philippines, Population (million), 2008-2015 136
  • Table 35: Demographics, Philippines, Population (million), 2016-2020 137
  • Table 36: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2008-2015 138
  • Table 37: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2016-2020 139
  • Table 38: Demographics, Philippines, Population Distribution by Age Group (%), 2008-2015 140
  • Table 39: Demographics, Philippines, Population Distribution by Age Group (%), 2016-2020 141
  • Table 40: Demographics, Philippines, Births (per 1,000 population), 2008-2014 142
  • Table 41: Demographics, Philippines, Mortality (per 1,000 population), 2008-2014 143
  • Table 42: Demographics, Philippines, Major Causes of Mortality ('000), 2013 144
  • Table 43: Demographics, Philippines, Infant Mortality (per 1,000 live births), 2008-2015 146
  • Table 44: Demographics, Philippines, Immunization Rate (%), 2008-2014 147
  • Table 45: Demographics, Philippines, Major Causes of Male Mortality ('000), 2013 148
  • Table 46: Demographics, Philippines, Major Causes of Female Mortality ('000), 2013 149
  • Table 47: Demographics, Philippines, Maternal Mortality (per 1,000 live births), 2008-2014 150
  • Table 48: Demographics, Philippines, Gender Ratio (M/F), 2008-2014 151
  • Table 49: Demographics, Philippines, Life Expectancy at Birth (years), 2008-2015 152
  • Table 50: Demographics, Philippines, Life Expectancy at Birth (years), 2016-2020 153
  • Table 51: Demographics, Philippines, Student Enrollment by Level of Education (%), 2008-2014 154
  • Table 52: Demographics, Philippines, Unemployment Rate (%), 2008-2015 155
  • Table 53: Demographics, Philippines, Major Diseases, Morbidity ('000), 2013 157
  • Table 54: Demographics, Philippines, Major Diseases, DALYs (per 100,000 population), 2009 159
  • Table 55: Healthcare Infrastructure, Philippines, Hospitals, 2008-2014 160
  • Table 56: Healthcare Infrastructure, Philippines, Barangay Health Stations, 2008-2014 161
  • Table 57: Healthcare Infrastructure, Philippines, Hospitals by Standard of Care, 2009 162
  • Table 58: Healthcare Infrastructure, Philippines, Diagnostic Equipment (per 100,000 population), 2007-2009 163
  • Table 59: Healthcare Infrastructure, Philippines, Hospitals Beds (per 10,000 population), 2008-2014 164
  • Table 60: Environmental Health, Philippines, CO2 Emissions (million metric tons), 2008-2014 166
  • Table 61: Environmental Health, Philippines, PM2.5 (µg/m³), 2008-2014 167
  • Table 62: Healthcare Personnel, Philippines, Registered Healthcare Personnel, 2008-2014 168
  • Table 63: Healthcare Personnel, Philippines, Registered Nurses, 2008-2014 169
  • Table 64: Healthcare Expenditure, Philippines, Healthcare Expenditure (% of GDP), 2008-2014 170
  • Table 65: Healthcare Expenditure, Philippines, Share of Major Components (%), 2013 171
  • Table 66: Healthcare Expenditure, Philippines, Public-Private Share (%), 2008-2014 172
  • Table 67: Healthcare Market, Philippines, Major Trade Fairs, 2016 174

List of Figures

1.2 List of Figures

  • Figure 1: Pharmaceutical Market, Philippines, Revenue ($bn), 2008-2015 19
  • Figure 2: Pharmaceutical Market, Philippines, Revenue Forecast ($bn), 2016-2020 20
  • Figure 3: Pharmaceutical Market, Philippines, Exports and Imports ($m), 2008-2014 21
  • Figure 4: Pharmaceutical Distribution Channel, Philippines, Distribution Share (%), 2008 22
  • Figure 5: Pharmaceutical Market, Philippines, Price Distribution of Pharmaceuticals for Multinational Companies (%), 2008 23
  • Figure 6: Healthcare Market, Philippines, Drivers and Barriers, 2016 69
  • Figure 7: Healthcare Market, Philippines, Healthcare System, 2016 70
  • Figure 8: Healthcare Market, Philippines, Drug Selection Procedure for Philippine National Drug Formulary, 2016 73
  • Figure 9: Healthcare Market, Philippines, Reimbursement Process, 2016 74
  • Figure 10: Healthcare Market, Philippines, PhilHealth Milestones, 2016 77
  • Figure 11: Membership in PhilHealth, Philippines, Sector Share (%), 2016 78
  • Figure 12: Benefit Payments from PhilHealth, Philippines, Sector Share (%), 2016 79
  • Figure 13: Healthcare Spending, Philippines, Out-of-Pocket Expenditure (%), 2008-2015 81
  • Figure 14: Price of Healthcare Products, Philippines, Change in Average Price of Health Sector (%), 2008-2014 82
  • Figure 15: Healthcare Market, Philippines, Food and Drug Administration Structure, 2014 85
  • Figure 16: Philippines, Healthcare Market, Approval Process of New Drugs and Medical Devices, 2014 88
  • Figure 17: Healthcare Market, Philippines, Approval Process of Generic Drugs, 2016 90
  • Figure 18: Healthcare Market, Philippines, Bureau of Health Devices and Technology Structure, 2016 91
  • Figure 19: Healthcare Market, Philippines, Licensing Process for Manufacture of Pharmaceuticals and Medical Devices, 2016 92
  • Figure 20: Healthcare Market, Philippines, Patent Approval Process, 2016 97
  • Figure 21: Healthcare Market, Philippines, Trademark Approval Process, 2016 98
  • Figure 22: Healthcare Market, Philippines, Clinical Trial Approval Process, 2014 101
  • Figure 23: Healthcare Market, Philippines, Procedure for Opening a Retail Pharmacy, 2014 103
  • Figure 24: Healthcare Policy Initiatives, Philippines, Major Healthcare Reforms, 1999-2014 112
  • Figure 25: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2008-2015 118
  • Figure 26: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2016-2020 119
  • Figure 27: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2008-2015 120
  • Figure 28: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2016-2020 121
  • Figure 29: Economic Indicators, Philippines, Gross National Income per Capita ($), 2008-2014 122
  • Figure 30: Economic Indicators, Philippines, Average Consumer Price Index, 2008-2013 123
  • Figure 31: Economic Indicators, Philippines, Average Consumer Price Annual Change (%), 2008-2013 124
  • Figure 32: Economic Indicators, Philippines, Currency Exchange Rate (PHP/$), 2008-2015 125
  • Figure 33: Economic Indicators, Philippines, Foreign Direct Investment ($bn), 2008-2014 126
  • Figure 34: Economic Indicators, Philippines, Foreign Exchange Reserves ($bn), 2008-2014 127
  • Figure 35: Economic Indicators, Philippines, Imports of Goods and Services ($bn), 2008-2015 128
  • Figure 36: Economic Indicators, Philippines, Exports of Goods and Services ($bn), 2008-2015 129
  • Figure 37: Economic Indicators, Philippines, Fiscal Deficit (% of GDP), 2008-2014 130
  • Figure 38: Economic Indicators, Philippines, General Government Gross Debt (% of GDP), 2008-2015 131
  • Figure 39: Economic Indicators, Philippines, External Debt ($bn), 2008-2015 132
  • Figure 40: Economic Indicators, Philippines, Major Industries, Industrial Sector, Gross Value Added ($bn), 2013-2014 133
  • Figure 41: Economic Indicators, Philippines, Major Industries, Service Sector, Gross Value Added ($bn), 2013-2014 134
  • Figure 42: Demographics, Philippines, Population (million), 2008-2015 136
  • Figure 43: Demographics, Philippines, Population (million), 2016-2020 137
  • Figure 44: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2008-2015 138
  • Figure 45: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2016-2020 139
  • Figure 46: Demographics, Philippines, Population Distribution by Age Group (%), 2008-2015 140
  • Figure 47: Demographics, Philippines, Population Distribution by Age Group (%), 2016-2020 141
  • Figure 48: Demographics, Philippines, Births (per 1,000 population), 2008-2014 142
  • Figure 49: Demographics, Philippines, Mortality (per 1,000 population), 2008-2014 143
  • Figure 50: Demographics, Philippines, Major Causes of Mortality ('000), 2013 144
  • Figure 51: Demographics, Philippines, Infant Mortality (per 1,000 live births), 2008-2015 145
  • Figure 52: Demographics, Philippines, Immunization Rate (%), 2008-2014 146
  • Figure 53: Demographics, Philippines, Major Causes of Male Mortality ('000), 2013 147
  • Figure 54: Demographics, Philippines, Major Causes of Female Mortality ('000), 2013 149
  • Figure 55: Demographics, Philippines, Maternal Mortality (per 1,000 live births), 2008-2014 150
  • Figure 56: Demographics, Philippines, Gender Ratio (M/F), 2008-2014 151
  • Figure 57: Demographics, Philippines, Life Expectancy at Birth (years), 2008-2015 152
  • Figure 58: Demographics, Philippines, Life Expectancy at Birth (years), 2016-2020 153
  • Figure 59: Demographics, Philippines, Student Enrollment by Level of Education (%), 2008-2014 154
  • Figure 60: Demographics, Philippines, Unemployment Rate (%), 2008-2015 155
  • Figure 61: Demographics, Philippines, Major Diseases, Morbidity ('000), 2013 156
  • Figure 62: Demographics, Philippines, Major Diseases, DALYs (per 100,000 population), 2009 158
  • Figure 63: Healthcare Infrastructure, Philippines, Hospitals, 2008-2014 160
  • Figure 64: Healthcare Infrastructure, Philippines, Barangay Health Stations, 2008-2014 161
  • Figure 65: Healthcare Infrastructure, Philippines, Hospitals by Standard of Care, 2009 162
  • Figure 66: Healthcare Infrastructure, Philippines, Diagnostic Equipment (per 100,000 population), 2007-2009 163
  • Figure 67: Healthcare Infrastructure, Philippines, Hospitals Beds (per 10,000 population), 2008-2014 164
  • Figure 68: Environmental Health, Philippines, CO2 Emissions (million metric tons), 2008-2014 166
  • Figure 69: Environmental Health, Philippines, PM2.5 (µg/m³), 2008-2014 167
  • Figure 70: Healthcare Personnel, Philippines, Registered Healthcare Personnel, 2008-2014 168
  • Figure 71: Healthcare Personnel, Philippines, Registered Nurses, 2008-2014 169
  • Figure 72: Healthcare Expenditure, Philippines, Healthcare Expenditure (% of GDP), 2008-2014 170
  • Figure 73: Healthcare Expenditure, Philippines, Share of Major Components (%), 2013 171
  • Figure 74: Healthcare Expenditure, Philippines, Public-Private Share (%), 2008-2014 172
  • Figure 75: Healthcare Market, Philippines, Opportunities and Challenges, 2016 177
Back to Top